Wordt geladen...
Immunotherapy in the landscape of new targeted treatments for non‐small cell lung cancer
Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related death worldwide. Active immunotherapies and molecules targeting tyrosine kinase receptors both offer new avenues for the treatment of NSCLC. Furthermore, their combinations or their administration along with standard treatment...
Bewaard in:
| Gepubliceerd in: | Mol Oncol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527544/ https://ncbi.nlm.nih.gov/pubmed/19846354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2009.09.001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|